FDA label

What is Motpoly XR used for?

Motpoly XR contains lacosamide. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label for Motpoly XR lists 2 uses: Partial-Onset Seizures; Primary Generalized Tonic-Clonic Seizures.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Motpoly XR?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Motpoly XR, capsule, extended release

Indications and Usage, quoted from the label by Aucta Pharmaceuticals, Inc. (NDA216185). Cross-references to other label sections are left out.

Partial-Onset Seizures

MOTPOLY XR is indicated for the treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg.

Primary Generalized Tonic-Clonic Seizures

MOTPOLY XR is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and in pediatric patients weighing at least 50 kg.

Additional pediatric use information is approved for UCB Inc.'s Vimpat (lacosamide) tablets, oral solution, and intravenous solution. However, due to UCB Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Source: DailyMed label, set id fb8235b4-4cd3-6f22-e053-6294a90a545c, version 5, effective July 16, 2025. NDC 73289-0063, one of 3 listings for this product.

Questions

What is Motpoly XR used for?

The FDA label for Motpoly XR lists 2 uses: Partial-Onset Seizures; Primary Generalized Tonic-Clonic Seizures.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Motpoly XR

Try it on your own data today.

Free to start. Most teams are using it the same day.